Circular RNA ciRS-7—A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer
Open Access
- 13 July 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 23 (14) , 3918-3928
Abstract
Purpose: Colorectal cancer is one of the most common malignancies worldwide. Recently, a novel circular RNA, ciRS-7, was proposed to be a potential miR-7 sponge. As miR-7, a putative tumor-suppressor, regulates the expression of several important drivers of colorectal cancer, we analyzed the clinical significance of ciRS-7 in colorectal cancer patients. Experimental Design: Initially, we evaluated the expression levels of ciRS-7 in a training cohort comprising of 153 primary colorectal cancer tissues and 44 matched normal mucosae. We subsequently confirmed its clinical relevance in an independent validation cohort (n = 165), and evaluated the effect of ciRS-7 on miR-7, and its target genes EGFR and RAF1. Functional analyses were performed in cell lines and an animal model to support clinical findings. Results: Our data revealed that ciRS-7 was significantly upregulated in colorectal cancer tissues compared with matched normal mucosae (P = 0.0018), and its overexpression was associated with poor patient survival (P = 0.0224 and 0.0061 in the training and validation cohorts, respectively). Multivariate survival analysis revealed that ciRS-7 emerged as an independent risk factor for overall survival (P = 0.0656 and 0.0324 in the training and validation cohorts, respectively). Overexpression of ciRS-7 in HCT116 and HT29 cells led to the blocking of miR-7 and resulted in a more aggressive oncogenic phenotype, and ciRS-7 overexpression permitted the inhibition of miR-7 and subsequent activation of EGFR and RAF1 oncogenes. Conclusions: CiRS-7 is a promising prognostic biomarker in colorectal cancer patients and may serve as a therapeutic target for reducing EGFR-RAF1 activity in colorectal cancer patients. Clin Cancer Res; 23(14); 3918–28. ©2017 AACR.Keywords
All Related Versions
Funding Information
- National Cancer Institute (R01 CA72851, CA181572, CA184792, and U01 CA187956)
- National Natural Science Foundation of China (81372615)
- Shanghai Health System Outstanding Young Talent Training Plan (XYQ2013118)
This publication has 45 references indexed in Scilit:
- Epigenetic and genetic features of 24 colon cancer cell linesOncogenesis, 2013
- MicroRNA‐7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cellsFEBS Letters, 2013
- Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancerOncogene, 2012
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- Current Progress on Understanding MicroRNAs in Glioblastoma MultiformeGenes & Cancer, 2012
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomesJournal of Biomedical Informatics, 2011
- Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7Journal of Biological Chemistry, 2009
- The UL12.5 Gene Product of Herpes Simplex Virus Type 1 Exhibits Nuclease and Strand Exchange Activities but Does Not Localize to the NucleusJournal of Virology, 2004
- Myocardin Expression Is Regulated by Nkx2.5, and Its Function Is Required for CardiomyogenesisMolecular and Cellular Biology, 2003
- A genetic model for colorectal tumorigenesisCell, 1990